Mother-to-Child HIV Transmission among Pregnant Women in a City with the Highest Rates of HIV in Brazil

Abstract

Objective Most of the HIV pediatric infections are acquired through mother-to-child transmission (MTCT). Porto Alegre is a state capital of Brazil that had a HIV MTCT rate of 4.1% in 2013 and the highest rate of HIV-infected pregnant women in the country during 2018. Zidovudine and nevirapine have been used in Brazil for high-risk newborns since 2012. The aim of the study was to investigate HIV MTCT rate and the factors associated with HIV transmission at a hospital that is a reference center for HIV-infected mothers in Porto Alegre, after the introduction of this policy.

Study Design This retrospective cohort study included all HIV-exposed infants born between February 2013 and December 2016 at the Hospital de Clínicas de Porto Alegre. Student's t-test or Fisher's exact test was used to compare variables between HIV-infected and uninfected groups of newborns. Poisson's regression with robust variance was used to determine the factors associated with HIV MTCT.

Results A total of 375 newborns were exposed to HIV, with an outpatient loss of 14.4% (n = 54). The HIV MTCT rate was 2.18% (n = 7), with four infected during the intrauterine period. The risk factors for MTCT were no prenatal care (relative risk [RR] = 9.4; 95% confidence interval [CI]: 2.0–44.3), late maternal HIV diagnosis in the peripartum period (RR = 16.3; 95% CI: 3.6–73.0), syphilis infection during pregnancy (RR = 9.3; 95% CI: 2.1–40.3), maternal viral load >1,000 copies/mL in the third trimester or peripartum period (RR = 9.5; 95% CI: 1.7–50.5), and lack of or inappropriate antiretroviral therapy during pregnancy (RR = 8.2; 95% CI: 1.6–41.4).

Conclusion MTCT rate was 2.18%. With the institution of two-drug prophylaxis for high-risk newborns, persistent cases HIV MTCT were predominantly found among women with absence of antenatal care, late HIV diagnosis, syphilis coinfection, high viral load, and inadequate ARV therapy during pregnancy. Although zidovudine and nevirapine were administered postnatally to high-risk newborns, this regimen could not prevent transplacental transmission.

Key Points

• Most of the HIV pediatric infections are acquired through mother-to-child transmission.

• The study investigated HIV MTCT rate and the factors associated with HIV transmission in Brazil.

• HIV MTCT rate was 2.18% and most of them were infected during the intrauterine period.

Keywords

infectious disease transmission - vertical - HIV - nevirapine - zidovudine - maternal health - Brazil

Publikationsverlauf

Eingereicht: 05. Mai 2020

Angenommen: 04. Dezember 2020

Artikel online veröffentlicht:
21. Januar 2021

• References

• 1 John GC, Nduati RW, Mbori-Ngacha DA. et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001; 183 (02) 206-212
• 2 Luzuriaga K, Mofenson LM. Challenges in the Elimination of Pediatric HIV-1 Infection. N Engl J Med 2016; 374 (08) 761-770
• 3 World Health Organization. Global Update on the Health Sector Response to HIV, 2014. Accessed December 22, 2020 at: https://apps.who.int/iris/bitstream/handle/10665/128494/9789241507585_eng.pdf;jsessionid=1E5737634837AC5812C114C097D6AEB8?sequence=1
• 4 UNAIDS. Relatório Informativo – Dia Mundial Contra a AIDS 2019: Estatísticas Globais Sobre HIV. Relatório Informativo. Accessed April 6, 2020 at: https://unaids.org.br/wp-content/uploads/2019/11/2019_UNAIDS_WAD2019_FactSheet.pdf
• 5 UNAIDS. UNAIDS Data 2019. Accessed April 6, 2020 at: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf
• 6 World Health Organization. Global Guidance on Criteria and Processes for Validation: Elimination of Mother-to-Child Transmission of HIV and Syphilis. 2nd ed.. Geneva, Switzerland: World Health Organization; 2017
• 7 Ministério da Saúde, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. 2019. Accessed december 22, 2020 at: http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hivaids-2019
• 8 Equipe de Vigilância das Doenças Transmissíveis. Coordenadoria Geral de Vigilância em Saúde Secretaria Municipal de Saúde de Porto Alegre. Boletim Epidemiologico N ^o 73. Porto Alegre. Accessed December 22, 2020 at: http://lproweb.procempa.com.br/pmpa/prefpoa/cgvs/usu_doc/boletimepidemiologico-cgvs-sms-pmpa-73.pdf
• 9 Connor EM, Sperling RS, Gelber R. et al. Reduction of maternal-infant transmission of human immunodefiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331 (18) 1173-1180
• 10 Nielsen-Saines K, Watts DH, Veloso VG. et al; NICHD HPTN 040/PACTG 1043 Protocol Team. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 2012; 366 (25) 2368-2379
• 11 Fernandez AD, McNeeley DF. Management of the infant born to a mother infected with human immunodeficiency virus type 1 (HIV-1): current concepts. Am J Perinatol 2000; 17 (08) 429-436
• 12 Ministério da Saúde do Brasil. Protocolo Clínico E Diretrizes Terapêuticas Para Prevenção Da Transmissão Vertical Do HIV, Sífilis E Hepatites Virais. Accessed December 22, 2020 at: http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-prevencao-da-transmissao-vertical-de-hiv
• 13 Ministério da Saúde do Brasil. Nota técnica 388/2012. Accessed December 22, 2020 at: http://www.aids.gov.br/pt-br/legislacao/nota-tecnica-3882012
• 14 Ministério da Saúde do Brasil. Protocolo Clínico E Diretrizes Terapêuticas Para Manejo Da Infecção Pelo HIV Em Crianças E Adolescentes. Accessed December 22, 2020 at: http://www.aids.gov.br/pt-br/pub/2017/protocolo-clinico-e-diretrizes-terapeuticas-para-manejo-da-infeccao-pelo-hiv-em-criancas-e
• 15 Equipe de Vigilância das Doenças Transmissíveis Coordenadoria Geral de Vigilância em Saúde Secretaria Municipal de Saúde de Porto Alegre. Boletim Epidemiológico N ^o 52. Accessed December 22, 2020 at: http://lproweb.procempa.com.br/pmpa/prefpoa/cgvs/usu_doc/boletimepidemiologico-cgvs-sms-pmpa-52.pdf
• 16 Guimarães MF, Lovero KL, de Avelar JG. et al. Review of the missed opportunities for the prevention of vertical transmission of HIV in Brazil. Clinics (São Paulo) 2019; 74: e318
• 17 Domingues RMSM, Saraceni V, Leal MDC. Mother to child transmission of HIV in Brazil: Data from the “Birth in Brazil study”, a national hospital-based study. PLoS One 2018; 13 (02) e0192985
• 18 Delicio AM, Lajos GJ, Amaral E, Cavichiolli F, Polydoro M, Milanez H. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study. Reprod Health 2018; 15 (01) 76
• 19 Rosa MC, Lobato RC, Gonçalves CV. et al. Evaluation of factors associated with vertical HIV-1 transmission. J Pediatr (Rio J) 2015; 91 (06) 523-528
• 20 Castro AVG, Rodríguez SIG, Gazano AV. Transmisión vertical del virus de la inmunodeficiencia humana en mujeres usuarias del Centro Hospitalario nevirapina en niños uruguayos. Rev Med Urug (Montev) 2018; 34 (01) 39-47
• 21 Matos VTG, Batista FM, Versage NV. et al. High vertical HIV transmission rate in the Midwest region of Brazil. Braz J Infect Dis 2018; 22 (03) 177-185
• 22 da Cruz Gouveia PA, da Silva GA, de Fatima Pessoa Militão de Albuquerque M. Factors associated with mother-to-child transmission of the human immunodeficiency virus in Pernambuco, Brazil, 2000-2009. Trop Med Int Health 2013; 18 (03) 276-285
• 23 de Andrade SD, Sabidó M, Marcelo Monteiro W, Canellas L, Prazeres V, Schwartz Benzaken A. Mother-to-child transmission of HIV from 1999 to 2011 in the Amazonas, Brazil: risk factors and remaining gaps in prevention strategies. Pediatr Infect Dis J 2016; 35 (02) 189-195
• 24 Lovero KL, de Oliveira TRD, Cosme EM. et al. Retrospective analysis of risk factors and gaps in prevention strategies for mother-to-child HIV transmission in Rio de Janeiro, Brazil. BMC Public Health 2018; 18 (01) 1110
• 25 Hoffmann IC, Santos WM, Padoin Sde M, Barros SM. A five-year review of vertical HIV transmission in a specialized service: cross-sectional study. Sao Paulo Med J 2016; 134 (06) 508-512
• 26 Fowler MG, Qin M, Fiscus SA. et al; IMPAACT 1077BF/1077FF PROMISE Study Team. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. N Engl J Med 2016; 375 (18) 1726-1737
• 27 Barbieri MM, Von Linsingen R, Sbalqueiro RL, Tristão EG. Vertical mother-to-child HIV transmission in babies born in a tertiary hospital in southern Brazil. J Matern Fetal Neonatal Med 2018; 31 (15) 2000-2006
• 28 Adachi K, Xu J, Yeganeh N. et al; NICHD HPTN 040 Study Team. Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission. PLoS One 2018; 13 (01) e0189851
• 29 Mcclelland RS, Wang CC, Mandaliya K. et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001; 15 (01) 105-110
• 30 Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008; 35 (11) 946-959
• 31 Sheffield JS, Sánchez PJ, Wendel Jr. GD. et al. Placental histopathology of congenital syphilis. Obstet Gynecol 2002; 100 (01) 126-133
• 32 Johnson EL, Chakraborty R. HIV-1 at the placenta: immune correlates of protection and infection. Curr Opin Infect Dis 2016; 29 (03) 248-255
• 33 Buchacz K, Patel P, Taylor M. et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18 (15) 2075-2079
• 34 Yeganeh N, Watts HD, Camarca M. et al; NICHD HPTN 040P1043 Study Team. Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study. Pediatr Infect Dis J 2015; 34 (03) e52-e57
• 35 Acosta LMW, Gonçalves TR, Barcellos NT. [HIV and syphilis coinfection in pregnancy and vertical HIV transmission: a study based on epidemiological surveillance data] (in Portuguese). Rev Panam Salud Publica 2016; 40 (06) 435-442
• 36 AIDSinfo. Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States. Accessed January 3, 2021 at: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Perinatal_GL_2020.pdf
• 37 Havens PL, Mofenson LM. American Academy of Pediatrics Committee on Pediatric AIDS. Evaluation and management of the infant exposed to HIV-1 in the United States. Pediatrics 2009; 123 (01) 175-187